白介素13抗体

Quantity size:

0.2ml

Concentration:

1mg/ml 白介素13抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Human IL13 was originally identified by differential screening of an anti CD28 activated human peripheral blood mononuclear cell cDNA library as an induction specific novel cytokine. It was also isolated from cDNA libraries of human T cell clones using the murine IL13 (P600)白介素13抗体   cDNA as a probe. Human IL13, a pleiotropic cytokine, is produced by activated Th0, Th1 like, Th2 like, and CD8 T cells. The gene for human IL13 maps to chromosome 5 and is closely linked to the genes for IL3, IL4, IL5, and GMCSF.
IL13 inhibits proinflammatory cytokine production and stimulates antibody production. It induces proliferation in the human pre myeloid cell line TF1. IL13 has multiple effects on the differentiation and functions of monocytes and macrophages.白介素13抗体   It suppresses cytotoxic functions and induces changes in the morphology of human monocytes and in the phenotype of human monocytes and B cells by upregulating MHC class II expression. IL13 will also decrease the production of nitric oxide by activated murine macrophages, leading to impaired parasiticidal activity.
Human and mouse interleukin 13 share approximately 58% amino acid sequence identity. Although human and mouse IL13 are equally active on human cells, human IL13 is much less active than mouse IL13 on mouse cells. Human IL13 and human IL4 also share approximately 30% sequence homology and have similar biological functions.

白介素13抗体  Also known as:

ALRH; BHR 1; BHR1; IL 13; IL13; Interleukin 13; Interleukin13; MGC116786; MGC116788; MGC116789; NC30; P600; IL13_MOUSE; Interleukin-13; IL-13; T-cell activation protein P600.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Sheep, .

●

Immunogen: KLH conjugated synthetic peptide derived from mouse IL-13 (4.

●

白介素13抗体  Predicted Molecular Weight: 12kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  Flow-Cyt=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl147Si01脂联素受体1(ADIPOR1)多克隆抗体Polyclonal Antibody to Adiponectin Receptor 1 (ADIPOR1)

kl149Hu01Ⅳ型胶原α1(COL4α1)多克隆抗体Polyclonal Antibody to Collagen Type IV Alpha 1 (COL4a1)

kl149Mu01Ⅳ型胶原α1(COL4α1)多克隆抗体Polyclonal Antibody to Collagen Type IV Alpha 1 (COL4a1)

kl149Ra01Ⅳ型胶原α1(COL4α1)多克隆抗体Polyclonal Antibody to Collagen Type IV Alpha 1 (COL4a1)

kl151Mu01激肽释放酶3(KLK3)多克隆抗体Polyclonal Antibody to Kallikrein 3 (KLK3)

kl151Si01激肽释放酶3(KLK3)多克隆抗体Polyclonal Antibody to Kallikrein 3 (KLK3)

kl154Hu01糖抗原125(CA125)多克隆抗体Polyclonal Antibody to Carbohydrate Antigen 125 (CA125)

kl154Mu01糖抗原125(CA125)多克隆抗体Polyclonal Antibody to Carbohydrate Antigen 125 (CA125)

kl159Hu01鳞状细胞癌抗原2(SCCA2)多克隆抗体Polyclonal Antibody to Squamous Cell Carcinoma Antigen 2 (SCCA2)

kl159Mu01鳞状细胞癌抗原2(SCCA2)多克隆抗体Polyclonal Antibody to Squamous Cell Carcinoma Antigen 2 (SCCA2)

kl160Bo01α2-纤溶酶抑制因子(α2PI)多克隆抗体Polyclonal Antibody to Alpha-2-Plasmin Inhibitor (a2PI)

kl160Hu01α2-纤溶酶抑制因子(α2PI)多克隆抗体Polyclonal Antibody to Alpha-2-Plasmin Inhibitor (a2PI)

kl160Mu01α2-纤溶酶抑制因子(α2PI)多克隆抗体Polyclonal Antibody to Alpha-2-Plasmin Inhibitor (a2PI)

kl160Ra01α2-纤溶酶抑制因子(α2PI)多克隆抗体Polyclonal Antibody to Alpha-2-Plasmin Inhibitor (a2PI)

kl160Rb51α2-纤溶酶抑制因子(α2PI)多克隆抗体Polyclonal Antibody to Alpha-2-Plasmin Inhibitor (a2PI)

kl162Bo01嗅素4(OLFM4)多克隆抗体Polyclonal Antibody to Olfactomedin 4 (OLFM4)

kl162Hu01嗅素4(OLFM4)多克隆抗体Polyclonal Antibody to Olfactomedin 4 (OLFM4)

kl162Mu01嗅素4(OLFM4)多克隆抗体Polyclonal Antibody to Olfactomedin 4 (OLFM4)

kl164Ga01泛素(Ub)多克隆抗体Polyclonal Antibody to Ubiquitin (Ub)

kl164Gu01泛素(Ub)多克隆抗体Polyclonal Antibody to Ubiquitin (Ub)

kl165Bo01胃蛋白酶原A(PGA)多克隆抗体Polyclonal Antibody to Pepsinogen A (PGA)